A detailed history of Ra Capital Management, L.P. transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 8,689,190 shares of PCVX stock, worth $746 Million. This represents 13.83% of its overall portfolio holdings.

Number of Shares
8,689,190
Previous 8,203,754 5.92%
Holding current value
$746 Million
Previous $619 Million 60.15%
% of portfolio
13.83%
Previous 9.34%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$70.52 - $117.12 $34.2 Million - $56.9 Million
485,436 Added 5.92%
8,689,190 $992 Million
Q2 2024

Aug 14, 2024

BUY
$60.06 - $78.77 $493 Million - $646 Million
8,203,754 New
8,203,754 $619 Million
Q1 2024

May 15, 2024

BUY
$59.79 - $81.05 $18.7 Million - $25.3 Million
312,500 Added 3.96%
8,203,754 $560 Million
Q4 2023

Feb 14, 2024

BUY
$45.35 - $63.41 $358 Million - $500 Million
7,891,254 New
7,891,254 $496 Million
Q2 2023

Aug 14, 2023

BUY
$34.66 - $54.07 $20.8 Million - $32.4 Million
600,000 Added 8.23%
7,891,254 $394 Million
Q1 2023

May 15, 2023

BUY
$36.27 - $47.2 $52 Million - $67.7 Million
1,433,795 Added 24.48%
7,291,254 $273 Million
Q4 2022

Feb 14, 2023

BUY
$20.58 - $47.95 $26.3 Million - $61.2 Million
1,276,256 Added 27.86%
5,857,459 $281 Million
Q1 2022

May 16, 2022

BUY
$17.46 - $26.36 $5.95 Million - $8.98 Million
340,739 Added 8.04%
4,581,203 $111 Million
Q4 2021

Feb 14, 2022

BUY
$19.32 - $26.45 $6.64 Million - $9.09 Million
343,599 Added 8.82%
4,240,464 $101 Million
Q3 2021

Nov 15, 2021

BUY
$20.26 - $26.97 $629,214 - $837,607
31,057 Added 0.8%
3,896,865 $98.9 Million
Q1 2021

May 17, 2021

BUY
$18.66 - $29.16 $2.89 Million - $4.52 Million
155,109 Added 4.18%
3,865,808 $76.4 Million
Q4 2020

Feb 16, 2021

SELL
$26.57 - $51.74 $41.8 Million - $81.4 Million
-1,573,119 Reduced 29.77%
3,710,699 $98.6 Million
Q3 2020

Nov 16, 2020

SELL
$26.5 - $55.4 $5.44 Million - $11.4 Million
-205,363 Reduced 3.74%
5,283,818 $261 Million
Q2 2020

Aug 14, 2020

BUY
$26.15 - $35.45 $144 Million - $195 Million
5,489,181 New
5,489,181 $174 Million

Others Institutions Holding PCVX

About Vaxcyte, Inc.


  • Ticker PCVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,315,100
  • Market Cap $5.1B
  • Description
  • Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...
More about PCVX
Track This Portfolio

Track Ra Capital Management, L.P. Portfolio

Follow Ra Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Ra Capital Management, L.P. with notifications on news.